NCT02576288View on ClinicalTrials.gov

Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
AtherosclerosisInflammation
Interventions
DRUG

Sitagliptin

anti-inflammatory properties

DRUG

Placebo

No anti-inflammatory properties

Trial Locations (1)

90033

University of Southern California Health Sciences Campus, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT02576288 - Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity | Biotech Hunter | Biotech Hunter